Investor Relations


SciClone Pharmaceuticals (NASDAQ: SCLN) is a revenue-generating, China-centric, specialty pharmaceutical company with a substantial international business and a product portfolio of novel therapies for cancer and infectious diseases. The Company is focused on continuing sales growth and

... More »

pdf SciClone Corporate Presentation September 2014.

pdf China Regulatory and Commercialization Backgrounder

Recent Releases

Sep 17, 2014
SciClone to Present at BioCentury NewsMakers in the Biotech Industry Conference on September 26, 2014

Sep 3, 2014
SciClone to Present at Aegis 2014 Healthcare & Technology Conference on September 11, 2014

View all releases »

Events & Presentations

Sep 26, 2014 at 11:30 AM ET
2014 BioCentury NewsMakers in the Biotech Industry Conference

Sep 11, 2014 at 10:45 AM PT
Aegis Capital Corp. 2014 Healthcare & Technology Conference

View all events & presentations »

Stock Chart
Stock price graph
3 Mo.   6 Mo.   1 Yr.
Stock Quote
SciClone Pharmaceuticals, Inc.
Price: 7.90
Change: 0.00
Day High: 7.99
Day Low: 7.77
Volume: 415,900
Delayed at least 20 minutes.
Provided by eSignal.